Publication dates

All regions

Recombinant Protein Industry, July 2014 Market Research & Statistics

You might be interested in: vaccine, antibody, drug, more »

1-10 of about 300 reports for Recombinant Protein

Lithuania - Economic Analysis

  • January 2012
    34 pages
  • Lithuania  

    World  

    Europe  

View report >

Analyst Report, 2012

  • January 2012
    6 pages
  • Australia  

View report >

Medical Industry in the US

  • Report to Congressional Committees
  • March 2014
    36 pages
  • Medical  

    Vaccine  

    Influenza Vacci...  

  • United States  

View report >

Pathology Description in the US - Forecast

  • Observer Jan 2013d
  • January 2012
    38 pages
  • Blood Disease  

    Hemophilia  

  • United States  

View report >

Pathology Description in India

  • Contribution of Hepatitis E Virus in Acute Sporadic Hepatitis in...
  • October 2012
    6 pages
  • Hepatitis  

  • India  

View report >

Pathology Description in India

  • Contribution of Hepatitis E Virus in Acute Sporadic Hepatitis in...
  • September 2012
    6 pages
  • Hepatitis  

  • India  

View report >

Pharmaceutical Markets in BRIC - Forecast

  • Truths & Untruths
  • January 2014
    19 pages
  • Pharmaceutical  

    Pharma Company  

  • Bric  

    World  

    United States  

View report >

Life Sciences Analysis in Brazil

  • Working Paper Nr. 5/2012
  • May 2012
    33 pages
  • Life Sciences  

  • Brazil  

    South America  

View report >

Genetic Industry in Australia

  • Economic Analysis of the Impact of Isolated Human Gene Patents
  • May 2013
    156 pages
  • Biotech  

    Genetic  

    Medical  

  • Australia  

    Oceania  

    United States  

View report >

Global Medicine Markets - Forecast

  • I Documenti Di
  • January 2013
    43 pages
  • Medicine  

  • Europe  

    United States  

    World  

View report >
47 reports for Recombinant Protein

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 6 650)

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.